These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 18303444)

  • 1. Systemic inflammation, cardiorespiratory fitness, and quality of life in patients with advanced non-small cell lung cancer.
    Jones LW; Eves ND; Mackey JR; Peddle CJ; Haykowsky M; Joy AA; Tankel K; Courneya KS; Reiman T
    J Thorac Oncol; 2008 Feb; 3(2):194-5. PubMed ID: 18303444
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiorespiratory fitness in patients with advanced non-small cell lung cancer: why is this feature important to evaluate? Can it be improved?
    Pujol JL; Quantin X; Chakra M
    J Thorac Oncol; 2009 May; 4(5):565-7. PubMed ID: 19357538
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety and feasibility of a combined exercise intervention for inoperable lung cancer patients undergoing chemotherapy: a pilot study.
    Quist M; Rørth M; Langer S; Jones LW; Laursen JH; Pappot H; Christensen KB; Adamsen L
    Lung Cancer; 2012 Feb; 75(2):203-8. PubMed ID: 21816503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of nutrition parameters including bioelectrical impedance and systemic inflammatory response with quality of life and prognosis in patients with advanced non-small-cell lung cancer: a prospective study.
    Sánchez-Lara K; Turcott JG; Juárez E; Guevara P; Núñez-Valencia C; Oñate-Ocaña LF; Flores D; Arrieta O
    Nutr Cancer; 2012; 64(4):526-34. PubMed ID: 22489794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of pemetrexed as a third- or fourth-line therapy and the significance of thymidylate synthase expression in patients with advanced non-small cell lung cancer.
    Chang MH; Ahn JS; Lee J; Kim KH; Park YH; Han J; Ahn MJ; Park K
    Lung Cancer; 2010 Sep; 69(3):323-9. PubMed ID: 20061047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Symptom burden and quality of life in advanced non-small cell lung cancer patients in France and Germany.
    Iyer S; Taylor-Stokes G; Roughley A
    Lung Cancer; 2013 Aug; 81(2):288-93. PubMed ID: 23561304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of presurgical exercise training on systemic inflammatory markers among patients with malignant lung lesions.
    Jones LW; Eves ND; Peddle CJ; Courneya KS; Haykowsky M; Kumar V; Winton TW; Reiman T
    Appl Physiol Nutr Metab; 2009 Apr; 34(2):197-202. PubMed ID: 19370050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perspectives on waiting on lung cancer.
    Mendyk SA
    Can Oncol Nurs J; 2009; 19(2):94-6. PubMed ID: 19757769
    [No Abstract]   [Full Text] [Related]  

  • 9. [Evaluation of the prognosis of patients with stage I non-small cell lung cancer with respect to predicted postoperative lung function].
    Koizumi K; Tanaka S; Haraguchi S; Matsushima S; Gomibuchi M
    Nihon Kyobu Geka Gakkai Zasshi; 1996 Feb; 44(2):162-8. PubMed ID: 8717264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-related quality of life in advanced non-small cell lung cancer: correlates and comparisons to normative data.
    Larsson M; Ljung L; Johansson BB
    Eur J Cancer Care (Engl); 2012 Sep; 21(5):642-9. PubMed ID: 22519874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosing and managing patients with lung cancer.
    Hunt P
    Nurs Stand; 2008 Apr 23-29; 22(33):50-6; quiz 58, 60. PubMed ID: 18540561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and feasibility of cardiopulmonary exercise testing in patients with advanced cancer.
    Jones LW; Eves ND; Mackey JR; Peddle CJ; Haykowsky M; Joy AA; Courneya KS; Tankel K; Spratlin J; Reiman T
    Lung Cancer; 2007 Feb; 55(2):225-32. PubMed ID: 17113185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between plasma hepatocyte growth factor and gefitinib resistance in patients with advanced non-small cell lung cancer.
    Han JY; Kim JY; Lee SH; Yoo NJ; Choi BG
    Lung Cancer; 2011 Nov; 74(2):293-9. PubMed ID: 21440951
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased serum levels of ghrelin at diagnosis mediate body weight loss in non-small cell lung cancer (NSCLC) patients.
    Karapanagiotou EM; Polyzos A; Dilana KD; Gratsias I; Boura P; Gkiozos I; Syrigos KN
    Lung Cancer; 2009 Dec; 66(3):393-8. PubMed ID: 19282046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Physical performance and psychosocial status in lung cancer patients: results from a pilot study.
    Hummler S; Thomas M; Hoffmann B; Gärtner P; Zoz M; Huber G; Ulrich CM; Wiskemann J
    Oncol Res Treat; 2014; 37(1-2):36-41. PubMed ID: 24613907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inoperable non-small cell lung cancer: palliative radiotherapy with two weekly fractions.
    Vyas RK; Suryanarayana U; Dixit S; Singhal S; Bhavsar DC; Neema JP; Baboo HA
    Indian J Chest Dis Allied Sci; 1998; 40(3):171-4. PubMed ID: 9919836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single-agent gefitinib in patients with untreated advanced non-small-cell lung cancer and poor performance status: a Minnie Pearl Cancer Research Network Phase II Trial.
    Spigel DR; Hainsworth JD; Burkett ER; Burris HA; Yardley DA; Thomas M; Jones SF; Dickson NR; Scullin DC; Bradof JE; Rubinsak JR; Brierre JE; Greco FA
    Clin Lung Cancer; 2005 Sep; 7(2):127-32. PubMed ID: 16179100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of pleural effusion in patients with non-small cell lung cancer.
    Sugiura S; Ando Y; Minami H; Ando M; Sakai S; Shimokata K
    Clin Cancer Res; 1997 Jan; 3(1):47-50. PubMed ID: 9815536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thymidylate synthase and dihydrofolate reductase expression in non-small cell lung carcinoma: the association with treatment efficacy of pemetrexed.
    Chen CY; Chang YL; Shih JY; Lin JW; Chen KY; Yang CH; Yu CJ; Yang PC
    Lung Cancer; 2011 Oct; 74(1):132-8. PubMed ID: 21367480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unsuspected pulmonary emboli in lung cancer patients: the impact on survival and the significance of anticoagulation therapy.
    Sun JM; Kim TS; Lee J; Park YH; Ahn JS; Kim H; Kwon OJ; Lee KS; Park K; Ahn MJ
    Lung Cancer; 2010 Sep; 69(3):330-6. PubMed ID: 20007002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.